3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
4
Rectal Neoplasms
1
Neoplasm Metastasis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Diseases
1
Brain Neoplasms
1
Interventions
tucatinib
1
pembrolizumab
1
XENP 1595
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Central Nervous System Diseases
×
tucatinib
×
Clear all
NCT04512261
2022-07-01
TOPAZ
Cedars-Sinai Medical Center
Phase 1/2
Withdrawn